PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS


Year of Award:
2004
Award Type:
R21
Project Number:
CA103548
RFA Number:
PAR-01-106
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
JAY, DANIEL G.
Other PI or Project Leader:
N/A
Institution:
TUFTS UNIVERSITY BOSTON
To address tumor diversity and their varied responses to chemotherapy, we require the ability to custom design treatment for each tumor. The goal of pharmacogenomics is to generate gene expression signatures for tissue using microarrays that are then corr